Valuation dashboard for Thermo Fisher Scientific Inc. (TMO) with P/E 35.36, P/B 4.64, EV/EBITDA 25.89 and dividend yield 0.28%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets.
Analysis Summary
Thermo Fisher Scientific Inc. reported revenue of $44.56B in the most recent fiscal year, growing at a 5-year CAGR of 6.7%. Net income reached $6.74B, with a 1.1% 5-year CAGR.
Trailing-twelve-month margins: gross margin 40.4%, operating margin 17.7%, net margin 15.1%.
At the current price of $658.32, TMO trades at a P/E of 35.36 and an ROE of 13.35%. Market capitalisation stands at $244.6B, placing it among large-cap names.
Balance sheet quality for TMO: current ratio of 1.9. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 35.36 |
| Price / Book | 4.64 |
| EV / EBITDA | 25.89 |
| Dividend Yield | 0.28% |
Valuation Models
| DCF Fair Value | $451.88 |
| vs Current Price | -31.4% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc. | $241.0B | 35.36 | 4.64 | 13.4% |
| MRK | Merck & Co., Inc. | $363.5B | 117.63 | 8.74 | 6.6% |
| AMGN | Amgen Inc. | $204.3B | 23.32 | 17.48 | 89.3% |
| ISRG | Intuitive Surgical, Inc. | $130.4B | 43.34 | 7.48 | 17.8% |
| AZN | AstraZeneca PLC | $253.8B | 24.74 | 5.09 | 21.7% |
| ABT | Abbott Laboratories | $176.8B | 32.91 | 3.49 | 10.5% |
| DHR | Danaher Corporation | $149.3B | 39.34 | 2.98 | 7.7% |
| A | Agilent Technologies, Inc. | $42.4B | 30.19 | 5.89 | 20.5% |
Price
| Price | $658.32 |
| Market Cap | $244.6B |
| Exchange | NYSE |
| Country | US |
Profitability
| Return on Equity | 13.35% |
| Return on Invested Capital | 7.44% |
| Return on Assets | 6.17% |
| Gross Margin | 40.37% |
| Operating Margin | 17.69% |
| Net Margin | 15.06% |
Related companies: A · ABT · AMGN · AZN · DHR · IQV · ISRG
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of TMO: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks